Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: J Immunol. 2017 Dec 18;200(3):1159–1168. doi: 10.4049/jimmunol.1700965

Figure 3. Activation of P2X4 contribute to the sustained phase of the ATP-evoked Ca2+ response.

Figure 3

A and B) Effect of P2X4 selective allosteric modulator (3 μM IVM; N=12 donors) represented as time response curves and area under the curve of Ca2+ response, respectively. C to F) Effect of P2X4 selective antagonist, 10 μM PSB-12062 (C and D; N=12 donors) and 5 μM BX430 (E and F; N=5 donors) represented as time response curves and area under the curve of Ca2+ response. G) Effect of co-application of selective P2X4 receptor antagonist and P2Y receptor antagonists (P2Y11 – NF340 and P2Y13 – MRS2211) on peak magnitude of Ca2+ response (N=4 donors). Statistical significance is represented as ** p<0.01.